Kathryn C. Fitzgerald

ORCID: 0000-0003-3137-0322
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Sclerosis Research Studies
  • Systemic Lupus Erythematosus Research
  • Peripheral Neuropathies and Disorders
  • Retinal and Optic Conditions
  • HIV/AIDS Research and Interventions
  • Systemic Sclerosis and Related Diseases
  • HIV-related health complications and treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Autoimmune Neurological Disorders and Treatments
  • Amyotrophic Lateral Sclerosis Research
  • Long-Term Effects of COVID-19
  • Tryptophan and brain disorders
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • Air Quality and Health Impacts
  • Ocular Diseases and Behçet’s Syndrome
  • Parkinson's Disease Mechanisms and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Psoriasis: Treatment and Pathogenesis
  • Genetic Associations and Epidemiology
  • Diet and metabolism studies
  • Skin and Cellular Biology Research
  • Glaucoma and retinal disorders
  • Dietary Effects on Health

Johns Hopkins Medicine
2017-2025

Johns Hopkins University
2016-2025

University of Manitoba
2017-2024

The University of Texas Southwestern Medical Center
2022-2024

Karolinska Institutet
2020-2024

United States Department of Veterans Affairs
2024

Max Delbrück Center
2024

Charité - Universitätsmedizin Berlin
2024

James A. Haley Veterans' Hospital
2024

National Institute on Aging
2024

<h3>Importance</h3> Persons with immune dysfunction have a higher risk for severe COVID-19 outcomes. However, these patients were largely excluded from SARS-CoV-2 vaccine clinical trials, creating large evidence gap. <h3>Objective</h3> To identify the incidence rate and ratio (IRR) breakthrough infection after vaccination among persons or without dysfunction. <h3>Design, Setting, Participants</h3> This retrospective cohort study analyzed data National COVID Cohort Collaborative (N3C),...

10.1001/jamainternmed.2021.7024 article EN JAMA Internal Medicine 2021-12-28

To assess the association between diet quality and intake of specific foods with disability symptom severity in people multiple sclerosis (MS).In 2015, participants North American Research Committee on MS (NARCOMS) Registry completed a dietary screener questionnaire that estimates fruits, vegetables legumes, whole grains, added sugars, red/processed meats. We constructed an overall score for each individual based these food groups; higher scores denoted healthier diet. assessed status as...

10.1212/wnl.0000000000004768 article EN Neurology 2017-12-06

Multiple sclerosis (MS) is an inflammatory demyelinating disorder of the CNS. Bile acids are cholesterol metabolites that can signal through receptors on cells throughout body, including in CNS and immune system. Whether bile acid metabolism abnormal MS unknown. Using global targeted metabolomic profiling, we identified lower levels circulating multiple cohorts adult pediatric patients with compared controls. In white matter lesions from brain tissue, noted presence glial cells. To...

10.1172/jci129401 article EN Journal of Clinical Investigation 2020-03-17
Adil Harroud Pernilla Stridh Jacob L. McCauley Janna Saarela Aletta M.R. van den Bosch and 95 more Hendrik J. Engelenburg Ashley Beecham Lars Alfredsson Katayoun Alikhani Lilyana Amezcua Till F. M. Andlauer Maria Ban Lisa F. Barcellos Nadia Barizzone Tone Berge Achim Berthele Stefan Bittner Steffan D. Bos Farren Briggs Stacy J. Caillier Peter A. Calabresi Domenico Caputo David X. Carmona-Burgos Paola Cavalla Elisabeth Gulowsen Celius Gabriel Cerono Ángel Chinea Tanuja Chitnis Ferdinando Clarelli Manuel Comabella Gıancarlo Comı Chris Cotsapas Bruce Cree Sandra D’Alfonso Efthimios Dardiotis Philip L. De Jager Silvia Delgado Bénédicte Dubois Sinah Engel Federica Esposito Marzena J. Fabis‐Pedrini Massimo Filippi Kathryn C. Fitzgerald Christiane Gasperi Lissette Gomez Refujia Gomez Georgios M. Hadjigeorgiou Jörg Hamann Friederike Held Roland G. Henry Jan Hillert Jesse Huang Inge Huitinga Talat Islam Noriko Isobe Maja Jagodic Allan G. Kermode Michael Khalil Trevor J. Kilpatrick Ioanna Konidari Karim L. Kreft Jeannette Lechner‐Scott Maurizio Leone Felix Luessi Sunny Malhotra Ali Manouchehrinia Clara P. Manrique Filippo Martinelli Boneschi Andrea C. Martinez Viviana Martínez-Maldonado Elisabetta Mascia Luanne M. Metz Luciana Midaglia Xavier Montalbán Jorge R. Oksenberg Tomas Olsson Annette Oturai Kimmo Pääkkönen Grant P. Parnell Nikolaos A. Patsopoulos Margaret A. Pericak‐Vance Fredrik Piehl Justin P. Rubio Adam Santaniello Silvia Santoro Catherine Schaefer Finn Sellebjerg Hengameh Shams Klementy Shchetynsky Cláudia Silva Vasileios Siokas Helle Bach Søndergaard Melissa Sorosina Bruce Taylor Marijne Vandebergh Eleni S. Vasileiou Domizia Vecchio Margarete M. Voortman Howard L. Weiner Dennis Wever

10.1038/s41586-023-06250-x article EN Nature 2023-06-28

Sphingosine-1-phosphate receptor (S1P) modulators and anti-CD20 therapies impair humoral responses to SARS-CoV-2 mRNA vaccines. Relatively few studies have assessed the impact of an array disease modifying (DMTs) for multiple sclerosis (MS) on T cell immune vaccination. In 101 people with MS, we measured via immunoassay measure IgG against COVID-19 spike S1 glycoprotein in serum. We also using FluoroSpot assay interferon gamma (IFN-γ) (Mabtech, Sweden) cryopreserved rested PBMCs then...

10.1016/j.ebiom.2021.103636 article EN cc-by-nc-nd EBioMedicine 2021-10-19

<h3>Importance</h3> Low serum 25-hydroxyvitamin D (25[OH]D) levels are associated with an increased risk of multiple sclerosis (MS) as well disease activity and rate progression in clinically isolated syndromes early MS. <h3>Objective</h3> To assess the association between 25(OH)D course prognosis patients relapsing-remitting MS treated interferon beta-1b. <h3>Design, Setting, Participants</h3> We conducted a prospective cohort study assessing subsequent characterized by magnetic resonance...

10.1001/jamaneurol.2015.2742 article EN JAMA Neurology 2015-10-13

Our objective was to determine if amyotrophic lateral sclerosis (ALS) risk varies according body mass index (BMI) captured up three decades earlier. At baseline 537,968 females and 562,942 males in five ongoing cohorts reported height, current weight at age 18/21 years. During 14–28 years of follow-up, 1153 participants developed ALS. Cohort-specific Cox proportional hazards models were used estimate rates that then pooled with random-effects models. Results showed lower BMI associated ALS;...

10.3109/21678421.2012.735240 article EN Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2012-10-29
Mitja Mitrovič Nikolaos A. Patsopoulos Ashley Beecham Theresa Dankowski An Goris and 95 more Bénédicte Dubois Marie D’hooghe Robin Lemmens Philip Van Damme Helle Bach Søndergaard Finn Sellebjerg Per Soelberg Sorensen Henrik Ullum Lise Wegner Thørner Thomas Werge Janna Saarela Isabelle Cournu‐Rebeix Vincent Damotte Bertrand Fontaine Léna Guillot‐Noël Mark Lathrop Sandra Vukusik Pierre‐Antoine Gourraud Till F. M. Andlauer Viola Pongratz Dorothea Buck Christiane Gasperi Antonios Bayas Christoph Heesen Tania Kümpfel Ralf A. Linker Friedemann Paul Martin Stangel Björn Tackenberg Florian Then Bergh Clemens Warnke Heinz Wiendl Brigitte Wildemann Uwe K. Zettl Ulf Ziemann Hayrettin Tumani Ralf Gold Verena Grummel Bernhard Hemmer Benjamin Knier Christina M. Lill Felix Luessi Efthimios Dardiotis Cristina Agliardi Nadia Barizzone Elisabetta Mascia Luisa Bernardinelli Giancarlo Comi Daniele Cusi Federica Esposito Laura Ferrè Cristoforo Comi Daniela Galimberti Maurizio Leone Melissa Sorosina Julia Mescheriakova Rogier Hintzen Cornelia M. van Duijn Charlotte E. Teunissen Steffan D. Bos Kjell‐Morten Myhr Elisabeth Gulowsen Celius Benedicte A. Lie Anne Spurkland Manuel Comabella Xavier Montalbán Lars Alfredsson Pernilla Stridh Jan Hillert Maja Jagodic Fredrik Piehl Ilijas Jelčić Roland Martinꝉ Mireia Sospedra Maria Ban Clive Hawkins Pirro G. Hysi Seema Kalra Fredrik Karpe Jyoti Khadake Geneviève Lachance Matthew Neville Adam Santaniello Stacy J. Caillier Peter A. Calabresi Bruce Cree Anne H. Cross Mary F. Davis Jonathan L. Haines Paul I. W. de Bakker Silvia Delgado Marieme Dembele Keith R. Edwards Kathryn C. Fitzgerald Hákon Hákonarson

Multiple sclerosis is a complex neurological disease, with ∼20% of risk heritability attributable to common genetic variants, including >230 identified by genome-wide association studies. strands evidence suggest that much the remaining also due additive effects variants rather than epistasis between these or mutations exclusive individual families. Here, we show in 68,379 cases and controls up 5% this explained low-frequency variation gene coding sequence. We identify four novel genes...

10.1016/j.cell.2018.09.049 article EN cc-by Cell 2018-10-18

BACKGROUND. Our goal was to identify changes in the metabolome multiple sclerosis (MS) and how vitamin D supplementation alters metabolic profiles MS patients healthy controls.

10.1172/jci.insight.95302 article EN JCI Insight 2017-10-04

To assess whether a high-salt diet, as measured by urinary sodium concentration, is associated with faster conversion from clinically isolated syndrome (CIS) to multiple sclerosis (MS) and MS activity disability.BENEFIT was randomized clinical trial comparing early versus delayed interferon beta-1b treatment in 465 patients CIS. Each patient provided median of 14 (interquartile range = 13-16) spot urine samples throughout the 5-year follow-up. We estimated 24-hour excretion level at each...

10.1002/ana.24965 article EN Annals of Neurology 2017-05-27

Loss of CDH1 (E-cadherin) expression in cancer cells may promote cell migration and invasion. Therefore, we hypothesised that loss colorectal carcinoma might be associated with aggressive features clinical outcome. Utilising molecular pathological epidemiology database 689 rectal colon cases the Nurses' Health Study Professionals Follow-up Study, assessed tumour by immunohistochemistry. Multivariate logistic regression analysis was conducted to assess association growth pattern...

10.1038/bjc.2015.347 article EN cc-by-nc-sa British Journal of Cancer 2016-01-01

Background: Comparative studies of characteristics optic neuritis (ON) associated with myelin oligodendrocyte glycoprotein-IgG (MOG-ON) and aquaporin-4-IgG (AQP4-ON) seropositivity are limited. Objective: To compare visual optical coherence tomography (OCT) measures following AQP4-ON, MOG-ON, multiple sclerosis ON (MS-ON). Methods: In this cross-sectional study, 48 16 40 MS-ON, 31 healthy control participants underwent monocular letter-acuity assessment spectral-domain OCT. Eyes a history...

10.1177/1352458519864928 article EN Multiple Sclerosis Journal 2019-07-31

Therapeutic development in progressive multiple sclerosis (PMS) has been hampered by a lack of reliable biomarkers to monitor neurodegeneration. Optical coherence tomography (OCT)-derived retinal measures have proposed as promising fulfill this role. However, it is unclear whether atrophy persists PMS, exceeds normal aging, or can be distinguished from relapsing-remitting (RRMS).178 RRMS, 186 and 66 control participants were followed with serial OCT for median follow-up 3.7 years.The...

10.1002/ana.25738 article EN Annals of Neurology 2020-04-14

Background: People with multiple sclerosis (MS) may be at higher risk for complications from the 2019 coronavirus (COVID-19) pandemic due to use of immunomodulatory disease modifying therapies (DMTs) and greater need medical services. Objectives: To evaluate factors COVID-19 susceptibility describe pandemic’s impact on healthcare delivery. Methods: Surveys sent MS patients Cleveland Clinic, Johns Hopkins, Vall d’Hebron-Centre d’Esclerosi Múltiple de Catalunya in April May 2020 collected...

10.1177/1352458520948231 article EN cc-by Multiple Sclerosis Journal 2020-08-10

To assess the effects of demographics, lifestyle factors, and comorbidities on serum neurofilament light chain (sNfL) levels in people without neurologic disease establish demographic-specific reference ranges sNfL.The National Health Nutrition Examination Survey (NHANES) is a representative sample US population which detailed information demographic, lifestyle, routine laboratory tests, overall health status are systematically collected. From stored samples, we measured sNfL using novel...

10.1002/ana.26446 article EN Annals of Neurology 2022-06-22

ObjectiveTo study in cerebrospinal fluid (CSF) of COVID-19 subjects if a "cytokine storm" or neuroinflammation are implicated pathogenesis neurological complications.MethodsCross-sectional CSF neuroinflammatory profiles from 18 with complications categorized by diagnosis (stroke, encephalopathy, headache) and illness severity. was compared healthy, infectious disorders stroke controls (n = 82). Cytokines (IL-6, TNFα, IFNγ, IL-10, IL-12p70, IL-17A), inflammation coagulation markers...

10.1016/j.jns.2021.117517 article EN other-oa Journal of the Neurological Sciences 2021-05-31

Rituximab is used widely for relapse prevention in neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein (MOG)-IgG-associated disease (MOGAD); however, data regarding the effectiveness safety of long-term rituximab use these conditions are limited. In this study, we sought to evaluate clinical outcomes patients with aquaporin-4 IgG-seropositive (AQP4-IgG+) NMOSD MOGAD treated rituximab.We performed a retrospective chart review AQP4-IgG+ or followed at Johns...

10.1212/wnl.0000000000201260 article EN Neurology 2022-08-31

BackgroundIntermittent fasting or calorie restriction (CR) diets provide anti-inflammatory and neuroprotective advantages in models of multiple sclerosis (MS); data humans are sparse.MethodsWe conducted a randomised-controlled feeding study different CR 36 people with MS over 8 weeks. Participants were randomised to 1 3 diets: 1) control diet, which the participant received 100% his her needs 7 days per week, 2) daily 78% 3) an intermittent on 5 week 25% 2 (i.e., "5:2" style diet)....

10.1016/j.ebiom.2022.104124 article EN cc-by-nc-nd EBioMedicine 2022-07-08

Background: The multiple sclerosis (MS) community is highly interested in diet as a potential protective factor against disability, but empirical evidence remains limited. Objective: Evaluate associations between patient-reported Mediterranean alignment and objective disability real-world MS cohort. Methods: Data were analyzed from persons with MS, aged 18–65, who completed the Diet Adherence Screener (MEDAS), Functional Composite (MSFC; primary metric), outcomes (PROs; gait disturbance,...

10.1177/13524585221127414 article EN Multiple Sclerosis Journal 2022-10-13
Coming Soon ...